產品詳情
簡單介紹：
Anti-EYA2抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-EYA2抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-EYA2
Cat. Number:
Anti-EYA2抗體KL-13125R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
A gene on chromosome 20q13.1 encodes Eya2 (eyes absent). EYA2 is one of four members of the eyes absent family. A 271 amino acid domain at the carboxy-terminal is highly conserved amongst the members of the eyes absent family, while the PST (proline-serive-threonin)-rich amino-terminal is highly divergent. EYA2 is expressed relatively late in development in the cytoplasm of extensor tendons and ligaments of the Anti-EYA2抗體phalangeal elements of the limb, cranial placodes, branchial arches, central nervous system, and the developing eye. Pax3 induces the expression of Eya2 in a cascade that is necessary and sufficient for myogenesis. EYA2, like EYA1, acts as a transcriptional activator in connective tissue patterning through its PST domain, which functions as a transactivation domain. EYA2 is translocated to the nucleus by Six proteins, which interact through their domain and homeodomain with EYA2. EYA2 carboxy-terminal interacts with the G Alpha z and G Alphai 2 proteins. This interaction prevents Six proteins from translocating EYA2 to the nucleus.
Also known as:
EAB 1; EAB1; EYA 2; EYA2; Anti-EYA2抗體EYA2_HUMAN; eyes absent 2 homolog (Drosophila); Eyes absent homolog 2; Translation of this uORF probably lowers the translation efficiency of EYA2.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human EYA2.
●
Predicted Molecular Weight: Anti-EYA2抗體59kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-EYA2抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl684Hu01 細胞因子信號轉導抑制因子3(SOCS3)多克隆抗體 Polyclonal Antibody to Suppressors Of Cytokine Signaling 3 (SOCS3)
kl685Mu01 整合素αM(ITGαM)多克隆抗體 Polyclonal Antibody to Integrin Alpha M (ITGaM)
kl685Ra01 整合素αM(ITGαM)多克隆抗體 Polyclonal Antibody to Integrin Alpha M (ITGaM)
kl686Hu01 B-細胞激活因子(BAFF)多克隆抗體 Polyclonal Antibody to B-Cell Activating Factor (BAFF)
kl686Mu01 B-細胞激活因子(BAFF)多克隆抗體 Polyclonal Antibody to B-Cell Activating Factor (BAFF)
kl686Ra01 B-細胞激活因子(BAFF)多克隆抗體 Polyclonal Antibody to B-Cell Activating Factor (BAFF)
kl688Hu01 白介素21(IL21)多克隆抗體 Polyclonal Antibody to Interleukin 21 (IL21)
kl688Mu01 白介素21(IL21)多克隆抗體 Polyclonal Antibody to Interleukin 21 (IL21)
kl688Ra01 白介素21(IL21)多克隆抗體 Polyclonal Antibody to Interleukin 21 (IL21)
kl689Hu01 白介素28A(IL28A)多克隆抗體 Polyclonal Antibody to Interleukin 28A (IL28A)
kl690Hu01 滲透性糖蛋白(Pgp)多克隆抗體 Polyclonal Antibody to Permeability Glycoprotein (Pgp)
kl691Hu01 角蛋白10(KRT10)多克隆抗體 Polyclonal Antibody to Keratin 10 (KRT10)
kl692Hu01 成肌分化蛋白(MyoD)多克隆抗體 Polyclonal Antibody to Myogenic Differentiation (MyoD)
kl692Ra01 成肌分化蛋白(MyoD)多克隆抗體 Polyclonal Antibody to Myogenic Differentiation (MyoD)
kl693Hu01 脂肪細胞型脂肪酸結合蛋白(FABP4)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 4, Adipocyte (FABP4)
kl693Ra01 脂肪細胞型脂肪酸結合蛋白(FABP4)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 4, Adipocyte (FABP4)
kl694Hu01 白介素25(IL25)多克隆抗體 Polyclonal Antibody to Interleukin 25 (IL25)
kl694Mu01 白介素25(IL25)多克隆抗體 Polyclonal Antibody to Interleukin 25 (IL25)
kl694Ra01 白介素25(IL25)多克隆抗體 Polyclonal Antibody to Interleukin 25 (IL25)
